| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/24/1991 | EP0423845A1 A synthetic gene encoding gamma-interferon |
| 04/24/1991 | EP0423317A1 Invasive microorganisms |
| 04/24/1991 | EP0423302A1 Application of novel dna fragments as a coding sequence for a signal peptide for the secretion of mature proteins by recombinant yeast, expression cassettes, transformed yeasts and corresponding process for the preparation of proteins. |
| 04/24/1991 | EP0423264A1 Recombinant cold shock protein, production and use in agriculture |
| 04/24/1991 | EP0423239A1 Post-transfusion, non-a, non-b hepatitis virus and antigens |
| 04/24/1991 | EP0423224A1 Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor |
| 04/24/1991 | EP0423207A1 A migration stimulating factor |
| 04/24/1991 | EP0423193A1 A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human |
| 04/24/1991 | CA2028172A1 Synthetic envelope peptides of htlv-i |
| 04/23/1991 | US5010182 DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides |
| 04/23/1991 | US5010015 Plasmid capable of multiplying in bacillus, regulation and secretion signal sequences of the amylase gene and the dna sequence encoding for the protein or polypeptide |
| 04/23/1991 | US5010000 Method for the preparation of a selected protein or a part thereof in Bacillus strain bacteria |
| 04/23/1991 | CA1283374C Recombinant dna expression vectors and method for gene expression |
| 04/23/1991 | CA1283373C Use of the gal 1 yeast promoter |
| 04/21/1991 | WO1991005805A1 MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR |
| 04/21/1991 | CA2028082A1 Modified heparin cofactor ii |
| 04/21/1991 | CA2028045A1 Infectious bronchitis virus vaccine |
| 04/21/1991 | CA2028024A1 Tumor-associated antigen |
| 04/19/1991 | WO1991005793A1 Production and use of human nm23 protein and antibodies therefor |
| 04/19/1991 | WO1991005565A1 BIOSYNTHETIC CONSTRUCTS OF TGF-$g(b) |
| 04/19/1991 | CA2070393A1 Biosynthetic constructs of tgf-beta |
| 04/18/1991 | WO1991005264A1 Detection and quantification of neu related proteins in the biological fluids of humans |
| 04/18/1991 | WO1991005059A1 Monoclonal antibody recognizing a pre-s1 region of the large envelope protein of the b hepatitis virus |
| 04/18/1991 | WO1991005058A1 Cell-free synthesis and isolation of novel genes and polypeptides |
| 04/18/1991 | WO1991005048A1 Mutants of the human plasminogen activator inhibitor 1 (pai-1), their preparation and use |
| 04/18/1991 | WO1991005047A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
| 04/18/1991 | WO1991005046A1 Granulocyte-colony stimulating factor receptors |
| 04/18/1991 | WO1991004747A1 Protection vaccine against swine hemophilosis |
| 04/18/1991 | WO1991004316A3 Ciliary neurotrophic factor |
| 04/18/1991 | WO1990015076A3 MONOCLONAL ANTIBODIES AGAINST LEUKOCYTE ADHESION RECEPTOR β-CHAIN, METHODS OF PRODUCING THESE ANTIBODIES AND USE THEREFORE |
| 04/18/1991 | DE3933850A1 Zytolyse-inhibitor (zli), eine diese blutplasmaprotein kodierende dna-sequenz, sowie ein plasmid, ein wirtsorganismus und ein verfahren zur gewinnung dieses proteins Cytolysis inhibitor (ZLI), these a blood plasma protein encoding DNA sequence, and a plasmid, a host organism and a method for obtaining this protein |
| 04/18/1991 | CA2027723A1 Use of glycoproteins extracted from gram-negative bacteria to produce cosmetic or dermatologic compositions, and compositions containing them |
| 04/17/1991 | WO1991005860A1 Non-infectious hiv-1 particles and uses therefor |
| 04/17/1991 | EP0422697A1 A consensus leukocyte interferon and a gene encoding it |
| 04/17/1991 | EP0422339A1 Tumor necrosis factor (TNF) inhibitor and method for obtaining the same |
| 04/17/1991 | EP0422217A1 Human recombinant placental ribonuclease inhibitor and method of production |
| 04/17/1991 | EP0422186A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
| 04/17/1991 | EP0422124A1 Thermal release of recombinant protein into culture media |
| 04/17/1991 | EP0422104A1 Angiogenic potentiating peptides which potentiate angiogenic factors |
| 04/17/1991 | EP0422037A1 Immunochemical assay for human granulocyte-macrophage colony stimulating factor |
| 04/17/1991 | CA2267658A1 Use of stem cell factor polypeptide to stimulate growth of epithelial cells |
| 04/17/1991 | CA2267643A1 Use of stem cell factor polypeptide as an anti-hematopoietic disorder agent |
| 04/17/1991 | CA2267626A1 Use of stem cell factor polypeptide to stimulate growth of stromal cells |
| 04/17/1991 | CA2067778A1 Non-infectious hiv-1 particles and uses therefor |
| 04/17/1991 | CA2027620A1 Vectors for generating transgenic fowl |
| 04/16/1991 | US5008377 Contacting with nuclear sulfonic acid cation ion exchange resin |
| 04/16/1991 | US5008374 IL-1α derivatives and drugs |
| 04/16/1991 | US5008371 Biologically active polypeptide and use thereof |
| 04/16/1991 | CA1283069C Vector capable of efficient gene expression and utilization of suchvector |
| 04/16/1991 | CA1283066C Monoclonal antibody specific to neutrophils |
| 04/16/1991 | CA1283043C T-cell lymphotrophic virus protein and assay |
| 04/11/1991 | DE3932310A1 New hybrid cell lines producing MABS to equine interferon-beta - for diagnosis of EQIFN-bets esp. enzyme immunoassays or therapy |
| 04/11/1991 | CA2027126A1 Compositions and methods for treating or preventing infections in canine and feline animals |
| 04/11/1991 | CA2025231A1 Cancer marker and monoclonal antibodies specific therefor |
| 04/10/1991 | EP0421935A2 Insect neuropeptides |
| 04/10/1991 | EP0421918A1 Pharmaceutical compositions |
| 04/10/1991 | EP0421876A1 Use of active agents in the preparation of a drug for the treatment of lymphomes or related diseases |
| 04/10/1991 | EP0421635A1 Chimaeric hepadnavirus core antigen proteins |
| 04/10/1991 | EP0421626A1 Vaccine for aids and hepatitis B |
| 04/10/1991 | EP0421392A1 Anti-hCG-beta core monoclonal antibody, its production and use |
| 04/10/1991 | EP0421382A1 Monoclonal antibody to exotoxin A of pseudomonas aeruginosa |
| 04/10/1991 | EP0421309A2 Protein hydrolysates |
| 04/10/1991 | EP0421284A1 Human endothelin-3 cDNA and use thereof |
| 04/10/1991 | EP0421099A2 Methods for modulating promoter responsible for beta amyloid precursor protein expression |
| 04/10/1991 | EP0421059A1 Purified ciliary neurotrophic factor |
| 04/10/1991 | EP0420894A1 Large scale method for purification of high purity heparinase. |
| 04/10/1991 | EP0277212A4 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor |
| 04/09/1991 | US5006652 Intermediates for antibody-vinca drug conjugates |
| 04/09/1991 | US5006472 Enzymatic purification process |
| 04/09/1991 | CA1282721C Herpes simplex virus as a vector |
| 04/09/1991 | CA1282696C Purification of hepatitis pre-s antigens by polymerized serum albumin affinity binding |
| 04/09/1991 | CA1282691C Monoclonal antibodies useful in the identification of microorganisms causing periodontal disease |
| 04/07/1991 | WO1991005043A1 Cytolysis inhibitor proteins (cli) and dna sequences coding for said proteins |
| 04/07/1991 | CA2042605A1 Cytolysis inhibitor proteins (cli), dna sequences coding for said proteins, and plasmids, host organisms, and processes for obtaining said proteins |
| 04/07/1991 | CA2027077A1 Application of active substances for the preparation of a drug for the treatment of lymphomas or related diseases, the drugs thus obtained and a process for the therapeutic treatment of lymphomas |
| 04/06/1991 | WO1991005066A1 Monoclonal antibodies to segments of hiv-1 reverse transcriptase |
| 04/06/1991 | CA2066171A1 Monoclonal antibodies to segments of hiv-1 reverse transcriptase |
| 04/05/1991 | CA2026803A1 Monoclonal antibody to exotoxin a of pseudomonas aeruginosa |
| 04/05/1991 | CA2025266A1 Anti-hcg-.beta. core monoclonal antibody, its production and use |
| 04/04/1991 | WO1991004490A1 Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
| 04/04/1991 | WO1991004339A1 Assays and reagents for amyloid deposition |
| 04/04/1991 | WO1991004328A1 Diagnosis for malignant hyperthermia |
| 04/04/1991 | WO1991004277A1 Monoclonal antibodies specific to cytomegalovirus glycoprotein |
| 04/04/1991 | WO1991004272A1 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| 04/04/1991 | WO1991004055A1 Treatment of autoimmune disease |
| 04/04/1991 | WO1991004049A1 CONJUGATE VACCINE FOR GROUP B $i(STREPTOCOCCUS) |
| 04/04/1991 | WO1991004036A1 TREPONEMA HYODYSENTERIAE ANTIGENS HAVING A MOLECULAR WEIGHT OF 39kDa AND DNA ENCODING THEREFOR |
| 04/04/1991 | WO1991001744A3 Uses of interleukin-4 and method for purifying it |
| 04/04/1991 | WO1991000100A3 Toxin uses |
| 04/04/1991 | DE3931839A1 Neue proteine und ihre herstellung New proteins and their production |
| 04/04/1991 | CA2383393A1 Conjugate vaccine for group b streptococcus |
| 04/03/1991 | EP0420759A1 Method of preparation of an immunizing composition |
| 04/03/1991 | EP0420743A1 Vaccine protecting against porcine hemophilus |
| 04/03/1991 | EP0420394A1 Monoclonal antibodies against a tumor-associated antigen |
| 04/03/1991 | EP0420151A1 Anti-rhodopsin monoclonal antibody and use thereof |
| 04/03/1991 | EP0420081A1 Monoclonal antibody against an acidic FGF protein, its production and use |
| 04/03/1991 | EP0420055A2 Enhanced gene expression in response to lactation signals |
| 04/03/1991 | EP0420043A1 Antibodies against highly conservated amino acid sequences of immunogenic substances, process of preparation of these antibodies and their use as immunoessays |
| 04/03/1991 | EP0420007A1 Method of purifying human serum albumin |
| 04/03/1991 | EP0419878A1 Aprotinin variants and a recombinant method for the microbial preparation of these variants in homogeneously processed form |